New application-specific LC system to precisely deliver high-purity products or isolation of contaminantsOctober 10, 2022
Thermo Fisher Scientific has recently announced the release of a new application-specific LC System: The Thermo Scientific Vanquish Analytical Purification LC system featuring the new integrated Vanquish Fraction Collector.
The new Vanquish Analytical Purification LC system combines the separation power of analytical LC with precise fractionation to generate high-purity products or for the isolation of contaminants. Moreover, with the introduction of the new integrated Vanquish Fraction Collector, a wide application range is covered, giving all users precision in purification across their whole analytical workflow.
Biopharma laboratories can now accurately fractionate with high recovery and low carry-over, with additional automation features that will allow researchers to focus on success in their process results instead of handling the tool. “We have two Vanquish Fraction Collectors and are running them 24/7 right now. No matter the fraction size, it is fractionated and afterwards reanalyzed. The team is thrilled, and these fraction collectors are running robustly with no errors,” said Dr. Alexander Schwenger, Senior Manager Analytical Development for CureVac AG, Germany.
“Biopharmaceutical laboratories working at the forefront of new drug development require detailed characterization of impurities. The superior user experience and separation performance of our award-winning Vanquish LC product line, with the addition of the new Vanquish Fraction Collector, enable researchers to isolate and purify compounds right after their analytical separation,” said Kent Davidson, vice president and general manager, high performance chromatography solutions, Thermo Fisher Scientific. “With our broad range of high-quality chromatographic consumables, our customers can be confident that sample integrity will be preserved throughout their analytical workflow. Our products can dramatically accelerate the science to get new life-saving drugs to the patient.”
Isolation of impurities or purification of active substances (antibodies, proteins, protein fragments, oligonucleotides, mRNA reagents, traditional medicines and natural products)
- Superior user experience with smart features and full fraction collector integration into the Vanquish platform under Thermo Scientific Chromeleon Chromatography Data system control
- Wide application flexibility supports a broad flow range from 0.05–10 mL/min and a wide variety of sample containers
- Compelling fraction purity performance using innovative valve technology for enhanced resolution, product recovery, and minimized carry-over
- Preserved sample integrity through fail-safe vessel rack recognition, precise fractionation movement, and controlled sample storage
- Optimal system setup with Viper Fingertight fittings and automated delay volume determination
- Confident biological sample processing through full system biocompatibility
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com